Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Eli Lilly’s lupus treatment succeeds in mid-stage trial
Lupus affects multiple organs and tissues in the body, causing symptoms that range from extreme fatigue and unexplained fever to…
Halol haze lifts, finally
It’s time to count the learnings from Halol, both internally for Sun Pharma as well as for India Pharma Inc
NPPA fixes price of 22 drug formulations
While NPPA has fixed retail prices of 20 formulations, it has also capped the ceiling prices of two formulations, a notification…
Cipla receives final approval for Generic Isuprel
The drug is indicated for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy
Lupin launches generic Tobramycin Inhalation Solution USP in US
Tobramycin Inhalation Solution USP will treat cystic fibrosis patients with P. aeruginosa
Bayer to acquire stake in Monsanto India
The deal resulted in Bayer group indirectly acquiring 72.14 per cent stake in Monsanto India
Johnson & Johnson announces progress toward health for humanity goals
Annual health for humanity report discloses progress on global commitments and highlights key achievements toward eradicating and…
Schreiner MediPharm and Schreiner ProTech wins FINAT Awards
For nearly two decades, Schreiner Group has been among the annual award winners of the FINAT Label Competition
OGT expands custom NGS cancer panel content
Researchers can select content from a wide range of available NGS panel content available for solid tumours
Sun Pharma receives EIR for Halol facility
Warning letter issued in December 2015 have been addressed